Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Kyverna Therapeutics, Inc. (KYTX) is the issuer named in an amended beneficial-ownership report by GordonMD Global Investments LP, GordonMD Long Biased Master Fund LP, GordonMD Long Biased GP LLC, Craig D. Gordon, and GordonMD Global Investments GP LLC. The report states that GordonMD Global Investments LP, Craig D. Gordon, and GordonMD Global Investments GP LLC each have shared voting and dispositive power over 4,521,318 shares (7.34%).
GordonMD Long Biased Master Fund LP and GordonMD Long Biased GP LLC each report shared voting and dispositive power over 4,198,616 shares (6.79%). The shares are directly owned by advisory clients of GordonMD Global Investments LP; the report identifies the master fund as the only such client that may be deemed to beneficially own more than 5% of KYTX common stock.
Key Figures
Beneficially owned shares:4,521,318 sharesPercent of class:7.34%Beneficially owned shares:4,198,616 shares+1 more
4 metrics
Beneficially owned shares4,521,318 sharesEach reported by GordonMD Global Investments LP, Craig D. Gordon, and GordonMD Global Investments GP LLC
Percent of class7.34%Reported by GordonMD Global Investments LP, Craig D. Gordon, and GordonMD Global Investments GP LLC
Beneficially owned shares4,198,616 sharesEach reported by GordonMD Long Biased Master Fund LP and GordonMD Long Biased GP LLC
Percent of class6.79%Reported by GordonMD Long Biased Master Fund LP and GordonMD Long Biased GP LLC
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powerregulatory
"Shared Voting Power 4,521,318.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared Dispositive Power 4,521,318.00"
advisory clientsfinancial
"All of the securities reported in this are directly owned by advisory clients"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many KYTX shares did the reporting persons report owning?
Three reporting persons each reported beneficial ownership of 4,521,318 shares, or 7.34%; two reported 4,198,616 shares, or 6.79%. The report also lists shared voting and dispositive power for those positions.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Kyverna Therapeutics, Inc.
(Name of Issuer)
Common Stock, par value $0.00001 per share
(Title of Class of Securities)
501976104
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
501976104
1
Names of Reporting Persons
GordonMD Global Investments LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,521,318.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,521,318.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,521,318.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.34 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
501976104
1
Names of Reporting Persons
GordonMD Long Biased Master Fund LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,198,616.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,198,616.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,198,616.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.79 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
501976104
1
Names of Reporting Persons
GordonMD Long Biased GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,198,616.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,198,616.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,198,616.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.79 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
501976104
1
Names of Reporting Persons
Craig D. Gordon
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,521,318.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,521,318.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,521,318.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.34 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
CUSIP Number(s):
501976104
1
Names of Reporting Persons
GordonMD Global Investments GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,521,318.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,521,318.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,521,318.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.34 %
12
Type of Reporting Person (See Instructions)
HC, OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Kyverna Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
5980 HORTON STREET, SUITE 200, EMERYVILLE, CA, 94608
Item 2.
(a)
Name of person filing:
GordonMD Global Investments LP
GordonMD Long Biased Master Fund LP
GordonMD Long Biased GP LLC
Craig D. Gordon
GordonMD Global Investments GP LLC
(b)
Address or principal business office or, if none, residence:
GordonMD Global Investments LP
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
GordonMD Long Biased Master Fund LP
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
GordonMD Long Biased GP LLC
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
Craig D. Gordon
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
GordonMD Global Investments GP LLC
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
(c)
Citizenship:
GordonMD Global Investments LP - Delaware
GordonMD Long Biased Master Fund LP - Cayman Islands
GordonMD Long Biased GP LLC - Delaware
Craig D. Gordon - United States
GordonMD Global Investments GP LLC - Delaware
(d)
Title of class of securities:
Common Stock, par value $0.00001 per share
(e)
CUSIP No.:
501976104
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
GordonMD Global Investments LP - 4,521,318
GordonMD Long Biased Master Fund LP - 4,198,616
GordonMD Long Biased GP LLC - 4,198,616
Craig D. Gordon - 4,521,318
GordonMD Global Investments GP LLC - 4,521,318
(b)
Percent of class:
GordonMD Global Investments LP - 7.34%
GordonMD Long Biased Master Fund LP - 6.79%
GordonMD Long Biased GP LLC - 6.79%
Craig D. Gordon - 7.34%
GordonMD Global Investments GP LLC - 7.34%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
GordonMD Global Investments LP - 0
GordonMD Long Biased Master Fund LP - 0
GordonMD Long Biased GP LLC - 0
Craig D. Gordon - 0
GordonMD Global Investments GP LLC - 0
(ii) Shared power to vote or to direct the vote:
GordonMD Global Investments LP - 4,521,318
GordonMD Long Biased Master Fund LP - 4,198,616
GordonMD Long Biased GP LLC - 4,198,616
Craig D. Gordon - 4,521,318
GordonMD Global Investments GP LLC - 4,521,318
(iii) Sole power to dispose or to direct the disposition of:
GordonMD Global Investments LP - 0
GordonMD Long Biased Master Fund LP - 0
GordonMD Long Biased GP LLC - 0
Craig D. Gordon - 0
GordonMD Global Investments GP LLC - 0
(iv) Shared power to dispose or to direct the disposition of:
GordonMD Global Investments LP - 4,521,318
GordonMD Long Biased Master Fund LP - 4,198,616
GordonMD Long Biased GP LLC - 4,198,616
Craig D. Gordon - 4,521,318
GordonMD Global Investments GP LLC - 4,521,318
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G are directly owned by advisory clients of GordonMD Global Investments LP. None of those advisory clients, other than GordonMD Long Biased Master Fund LP, may be deemed to beneficially own more than 5% of the Common Stock, par value $0.00001 per share.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Please see Exhibit B attached hereto.
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
N/A
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
N/A
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
GordonMD Global Investments LP
Signature:
/s/ GordonMD Global Investments GP LLC
Name/Title:
Craig D. Gordon, Managing Member of the General Partner
Date:
11/16/2026
GordonMD Long Biased Master Fund LP
Signature:
/s/ GordonMD Long Biased GP LLC
Name/Title:
GordonMD Long Biased GP LLC, Managing Member of the General Partner
Date:
11/16/2026
GordonMD Long Biased GP LLC
Signature:
/s/ Craig D. Gordon
Name/Title:
Craig D. Gordon, Managing Member
Date:
11/16/2026
Craig D. Gordon
Signature:
/s/ Craig D. Gordon
Name/Title:
Craig D. Gordon
Date:
11/16/2026
GordonMD Global Investments GP LLC
Signature:
/s/ Craig D. Gordon
Name/Title:
Craig D. Gordon, Managing Member
Date:
11/16/2026
Exhibit Information
Exhibit A - Joint Filing Agreement
Exhibit B - Control Person Identification